In silico methods, or using computer modelling and simulation (CM&S), is utilised to amplify and accelerate the design, development, testing and regulatory approval of new medical treatments. To achieve this goal, the healthcare community needs a clear and harmonised regulatory framework to ensure the necessary credibility of this approach for maximising patient safety while accelerating medical innovation.
In the last decade, policy makers from around the world have paid an increasing attention to this technology having the promise to accelerate medical innovation and make health care safer, more affordable, more effective and more efficient for their citizens. In addition, adopting this technology, widely used in other industries (such as aerospace, automotive or hightech among others), is also giving a clear competitive advantage to the industrial healthcare community operating in their region.
In leading regions, policy makers have facilitated research funding and built the legislative framework to validate computational models and encouraged their usage in faster regulatory approval process without compromising with safety and effectiveness for the benefits of local citizen and industries.
NEWS
Avicenna Alliance Submits MDR Revision Proposals to the European Commission
The Avicenna Alliance is pleased to announce that, in a letter sent to the European Commissioner for Health and Animal Welfare, Olivér Várhelyi, we have formally submitted our proposals for the revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to the European Commission.
Advancing In Silico Medicine: Strengthening Dialogue with EU Policymakers
On February 17, our President & Secretary General Thierry Marchal, alongside Nayara Maldonado Solís from RPP, had the opportunity to meet with the team of MEP Kulja, MD, to discuss the creation of an MEP In Silico Coalition. This initiative would establish a regular dialogue between in silico experts from the Avicenna Alliance and the VPH Institute, and MEPs committed to new technologies in healthcare.
Welcome to René Bombien, New Co-Chair of the Clinical Deployment Task Force
The Avicenna Alliance is pleased to welcome René Bombien as the new Co-Chair of the Clinical Deployment Task Force.
